Cargando…
Evolution of patient characteristics in the era of biologic treatment of psoriatic arthritis: 18-year Belgian experience from the Leuven Spondyloarthritis Biologics Cohort (BioSPAR)
OBJECTIVES: Biologic treatments have revolutionized the management of PsA by significantly improving clinical manifestations and preventing structural damage. Both result in better quality of life and improved physical functioning. Since the introduction of the first TNF inhibitor (TNFi) in the earl...
Autores principales: | Ishchenko, Alla, Joly, Johan, Neerinckx, Barbara, Lories, Rik, de Vlam, Kurt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651220/ https://www.ncbi.nlm.nih.gov/pubmed/34888434 http://dx.doi.org/10.1093/rap/rkab085 |
Ejemplares similares
-
Orthopaedic interventions in patients with psoriatic arthritis: a descriptive report from the SPAR cohort
por: Haque, Naba, et al.
Publicado: (2016) -
Evolution of psoriatic arthritis study patient population characteristics in the era of biological treatments
por: Vandendorpe, Ann-Sophie, et al.
Publicado: (2019) -
Systematic review of the use of CRP in clinical trials for psoriatic arthritis: a concern for clinical practice?
por: Houttekiet, Charlotte, et al.
Publicado: (2022) -
Extent of axial damage in psoriatic arthritis and spondyloarthritis: comparative data from the BEPAS and (Be-)GIANT multicentre cohorts
por: de Hooge, Manouk, et al.
Publicado: (2023) -
Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis
por: Lories, Rik JU, et al.
Publicado: (2009)